Cargando…
Issues in assessing products for the treatment of hemophilia – the intersection between efficacy, economics, and ethics
Following the obviation of the pathogen safety threats posed by previous generations of clotting factor concentrates for the treatment of hemophilia, the principal issue facing the patient community is timely access to adequate supplies of continuously improving therapies. The application of evidenc...
Autores principales: | Farrugia, Albert, Noone, Declan, Schlenkrich, Uwe, Schlenkrich, Steffen, O’Mahony, Brian, Cassar, Josephine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476485/ https://www.ncbi.nlm.nih.gov/pubmed/26124687 http://dx.doi.org/10.2147/JBM.S79091 |
Ejemplares similares
-
Assessing ethical climates in critical care and their impact on patient outcomes
por: Okenyi, Emmanuel, et al.
Publicado: (2019) -
Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders
por: Kaczmarek, Radoslaw, et al.
Publicado: (2021) -
Pap Smear Ransom – Is It Ethical to Refuse to Refill a Patient’s Birth Control Until They Come in for Their Annual Exam?
por: Marchand, Greg J, et al.
Publicado: (2020) -
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Naegel, Steffen, et al.
Publicado: (2010) -
A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole
por: Gentile, Salvatore
Publicado: (2009)